🇰🇷 Imferon in South Korea

Imferon (IRON DEXTRAN) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Imferon in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Hematology approved in South Korea

Frequently asked questions

Is Imferon approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Imferon in South Korea?

Marketing authorisation holder not available in our data.